Edition:
United Kingdom

People: Johnson & Johnson (JNJ.N)

JNJ.N on New York Stock Exchange

131.15USD
5:38pm BST
Change (% chg)

$-1.10 (-0.83%)
Prev Close
$132.25
Open
$131.96
Day's High
$132.62
Day's Low
$130.48
Volume
422,358
Avg. Vol
2,062,911
52-wk High
$148.97
52-wk Low
$122.00

Taubert, Jennifer 

Ms. Jennifer L Taubert is the Executive Vice President - Worldwide Chairman, Pharmaceuticals of the Company. She has joined the Company in 2005 as Worldwide Vice President at Johnson & Johnson Pharmaceutical Services, a subsidiary of the Company. She held several executive positions in the Pharmaceutical sector until 2012 when she was appointed Company Group Chairman, North America Pharmaceuticals, and in 2015 became Company Group Chairman, The Americas, Pharmaceuticals. In July 2018, Ms. Taubert was promoted to Executive Vice President, Worldwide Chairman, Pharmaceuticals, and became a member of the Executive Committee.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Award, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Alex Gorsky

20,097,600

Paulus Stoffels

10,591,800

Joaquin Duato

9,283,960

Joseph Wolk

2,708,190

Peter Fasolo

3,621,280

Michael Ullmann

5,336,150
As Of  31 Dec 2018